Advancing Platform Trials in Early Oncology by Using MATS and EXNEX in Randomized Controlled Trials
Crossref DOI link: https://doi.org/10.1007/s43441-026-00947-7
Published Online: 2026-03-18
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Zhe
Mi, Gu
Lin, Ji
Text and Data Mining valid from 2026-03-18
Version of Record valid from 2026-03-18
Article History
Received: 7 October 2025
Accepted: 22 February 2026
First Online: 18 March 2026
Declarations
:
: The authors declare no competing interests.